Filing Details
- Accession Number:
- 0001209191-15-009610
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-04 20:14:37
- Reporting Period:
- 2015-02-03
- Filing Date:
- 2015-02-04
- Accepted Time:
- 2015-02-04 20:14:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 244106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601949 | Paul Westberg | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | Sr. Vp, Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-03 | 5,000 | $1.27 | 27,487 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-03 | 4,629 | $17.34 | 22,858 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-03 | 371 | $18.10 | 22,487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-02-03 | 1,499 | $0.00 | 1,499 | $1.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-02-03 | 3,501 | $0.00 | 3,501 | $1.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 718 | 2021-03-29 | No | 4 | M | Direct | |
| 20,994 | 2021-03-29 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $17.00 to $17.89. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $18.00 to $18.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Twenty-five percent of the shares subject to the option vest on the first anniversary of the vesting commencement date and the remainder vest in equal monthly installments thereafter for 36 months.
Billionaire Hedge Funds
